Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Yanhui,Zhu ^[1] ; Hongfei,Zhang ^[1] ; Chaohu,Pan ^[2] ; Gao,He ^[3] ; Xiaoli,Cui ^[1] ; Xiafei,Yu ^[3] ; Xiaoqiang,Zhang ^[1] ; Dongfang,Wu ^[1] ; Junzhe,Yang ^[3] ; Xian,Wu ^[1] ; Haitao,Luo ^[1] ; Xiaoan,Liu ^[3]

作者单位： Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. ^[1] The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China. ^[2] Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, Guangdong, China. ^[3]

关键词 CD8 T cells M2 macrophages TMB TNBC biomarkers breast cancer neoadjuvant chemotherapy therapy

主题词人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);基因组学(Genomics);肿瘤微环境(Tumor Microenvironment)

DOI 10.1002/cam4.5372

PMID 36271505

发布时间 2023-03-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2023年12卷5期

5846-5858页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除